Kevin C. is an accomplished pharmaceutical executive currently serving as Vice President of the Ophthalmology Commercial Business Unit at Regeneron, where they lead initiatives for EYLEA HD and EYLEA. With a strong background in marketing, sales, digital, and market access, Kevin has a proven track record of successful brand launches and strategic partnerships. Prior to Regeneron, they held various leadership roles at Novartis and Aventis, where Kevin was instrumental in managing marketing strategies for several therapeutic products. Kevin earned their education at the University of Maryland College Park.
This person is not in the org chart
This person is not in any teams
This person is not in any offices